Cancer immunotherapy at the crossroads: how tumors evade immunity and what can be done
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Totowa, N.J.
Humana Press
2004
|
| Schriftenreihe: | Current clinical oncology
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | XVII, 386 S. Ill. |
| ISBN: | 1588291839 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV019636992 | ||
| 003 | DE-604 | ||
| 005 | 20050411 | ||
| 007 | t | ||
| 008 | 041217s2004 xxua||| |||| 00||| eng d | ||
| 010 | |a 2003014354 | ||
| 020 | |a 1588291839 |9 1-58829-183-9 | ||
| 035 | |a (OCoLC)52515832 | ||
| 035 | |a (DE-599)BVBBV019636992 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-20 | ||
| 050 | 0 | |a RC268.3 | |
| 082 | 0 | |a 616.99/4079 |2 21 | |
| 245 | 1 | 0 | |a Cancer immunotherapy at the crossroads |b how tumors evade immunity and what can be done |c edited by James H. Finke ... |
| 264 | 1 | |a Totowa, N.J. |b Humana Press |c 2004 | |
| 300 | |a XVII, 386 S. |b Ill. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Current clinical oncology | |
| 500 | |a Includes bibliographical references and index | ||
| 650 | 4 | |a Cancer - Immunologie | |
| 650 | 4 | |a Cancer - Immunothérapie | |
| 650 | 7 | |a Immunotherapie |2 gtt | |
| 650 | 7 | |a Kanker |2 gtt | |
| 650 | 4 | |a Antibody Formation | |
| 650 | 4 | |a Cancer |x Immunological aspects | |
| 650 | 4 | |a Cancer |x Immunotherapy | |
| 650 | 4 | |a Immunity, Cellular | |
| 650 | 4 | |a Immunotherapy |x methods | |
| 650 | 4 | |a Neoplasms |x immunology | |
| 650 | 4 | |a Neoplasms |x therapy | |
| 650 | 4 | |a T-Lymphocytes |x immunology | |
| 650 | 0 | 7 | |a Immuntherapie |0 (DE-588)4026640-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Immuntherapie |0 (DE-588)4026640-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Finke, James H. |e Sonstige |4 oth | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=012965959&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-012965959 | ||
Datensatz im Suchindex
| _version_ | 1804133007305474048 |
|---|---|
| adam_text | Contents
Dedication v
Preface vii
List of Contributors xiii
Part I. Basic Mechanisms of Immune Evasion
1 HLA Class I Antigen Processing Machinery and HLA Class I
Antigen Derived Peptide Complex Defects in Tumor Cell Escape 3
Michael Campoli, Chien Chung Chang, Xin Hui Wang,
and Soldano Ferrone
2 Immune Defects in T Cells From Cancer Patients:
Parallels in Infectious Diseases 35
Augusto C. Ochoa, Paulo C. Rodriguez, Jovanny Zabaleta,
Pelayo Correa, and Arnold H. Zea
3 Malfunction of the Dendritic Cell System in Cancer 49
Zoya R. Yurkovetsky, Irina L. Tourkova, Levent Balkir, Lori Perez,
Galina V. Shurin, Gurkamal S. Chatta, and Michael R. Shurin
4 CD4+ T Cell Mediated Immunity to Cancer 67
Tomohide Tatsumi, Amy Wesa, James H. Finke,
Ronald M. Bukowski, and Walter J. Storkus
5 Immunological Ignorance in Cancer 87
Koji Tamada and Lieping Chen
6 The Role of Receptor Mediated Apoptosis in T Cell Dysfunction 101
Hannah Rabinowich and Brian R. Gastman
7 Alterations in T Cell Signaling Pathways and Increased Sensitivity
to Apoptosis 119
Ithaar H. Derweesh, Luis Molto, Charles Tannenbaum,
Patricia Rayman, Christina Moon, Cynthia Combs, Thomas Olencki,
Paul Elson, Ronald M. Bukowski, and James H. Finke
8 The Role of Tumor Gangliosides in the Immune Dysfunction of Cancer... 145
Stephan Ladisch
9 Interleukin 10 Induced Immune Suppression in Cancer 157
Arvin S. Yang and Edmund C. Lattime
10 Accentuating Tumor Immunity Through Costimulation:
A Detailed Analysis ofOX40 Engagement and CTLA 4 Blockade 173
Andrew D. Weinberg, Dean E. Evans, and Arthur A. Hurwitz
xii Contents
11 Optimizing T Cell Adoptive Immunotherapy
to Overcome Tumor Evasion 195
Peter A. Cohen, Gregory E. Plautz, James H. Finke, and Suyu Shu
12 Tumor Resistance to Apoptosis: Mechanisms of Evasion
and Implications for Radiation and Chemotherapeutic Strategies 215
Robert G. Uzzo, Paul Cairns, Nickolai Dulin, Eric M. Horwitz,
Alan Pollack, and Vladimir Kolenko
Part II. Clinical Relevance of Immune Evasion
13 The Development and Reversal of T Cell Tolerance in Cancer Patients
Receiving Peptide Based Vaccines 237
Ena Wang and Francesco M. Marincola
14 Altered Signaling in T Lymphocytes of Patients With Cancer:
A Biomarker of Prognosis? 257
Theresa L. Whiteside
15 Allogeneic Hematopoietic Blood Cell Transplantation
as Immunotherapy for Metastatic Renal Cell Carcinoma 279
Richard W. Childs and Cristian A. Carvallo
16 Immune Defects in Patients Suffering
From Non Hodgkin s Lymphoma 295
Thomas Zander, Daniel Re, Michael von Bergwelt Baildon,
Jttrgen Wolf, and Joachim L. Schultze
17 Immune Dysfunction in Classical Hodgkin s Lymphoma 315
Arjan Diepstra, Ewerton M. Maggio, Anke van den Berg,
and Sibrand Poppema
18 Lung Cancer and Immune Dysfunction 335
Steven M. Dubinett, Sherven Sharma, Min Huang, Jenny T. Mao,
and Raj K. Batra
19 Primary Malignant Brain Tumors:
Immune Defects and Immune Evasion 351
Lucinda H. Elliott, Lorri A. Morford, William H. Brooks,
and Thomas L. Roszmam
Index 373
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV019636992 |
| callnumber-first | R - Medicine |
| callnumber-label | RC268 |
| callnumber-raw | RC268.3 |
| callnumber-search | RC268.3 |
| callnumber-sort | RC 3268.3 |
| callnumber-subject | RC - Internal Medicine |
| ctrlnum | (OCoLC)52515832 (DE-599)BVBBV019636992 |
| dewey-full | 616.99/4079 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/4079 |
| dewey-search | 616.99/4079 |
| dewey-sort | 3616.99 44079 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01925nam a2200541zc 4500</leader><controlfield tag="001">BV019636992</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20050411 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">041217s2004 xxua||| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2003014354</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1588291839</subfield><subfield code="9">1-58829-183-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)52515832</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV019636992</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-20</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC268.3</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4079</subfield><subfield code="2">21</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cancer immunotherapy at the crossroads</subfield><subfield code="b">how tumors evade immunity and what can be done</subfield><subfield code="c">edited by James H. Finke ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Totowa, N.J.</subfield><subfield code="b">Humana Press</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVII, 386 S.</subfield><subfield code="b">Ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Current clinical oncology</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer - Immunologie</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer - Immunothérapie</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunotherapie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Kanker</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibody Formation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Immunological aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Immunotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunity, Cellular</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunotherapy</subfield><subfield code="x">methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">T-Lymphocytes</subfield><subfield code="x">immunology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Immuntherapie</subfield><subfield code="0">(DE-588)4026640-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Immuntherapie</subfield><subfield code="0">(DE-588)4026640-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Finke, James H.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=012965959&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-012965959</subfield></datafield></record></collection> |
| id | DE-604.BV019636992 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T20:01:52Z |
| institution | BVB |
| isbn | 1588291839 |
| language | English |
| lccn | 2003014354 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-012965959 |
| oclc_num | 52515832 |
| open_access_boolean | |
| owner | DE-20 |
| owner_facet | DE-20 |
| physical | XVII, 386 S. Ill. |
| publishDate | 2004 |
| publishDateSearch | 2004 |
| publishDateSort | 2004 |
| publisher | Humana Press |
| record_format | marc |
| series2 | Current clinical oncology |
| spelling | Cancer immunotherapy at the crossroads how tumors evade immunity and what can be done edited by James H. Finke ... Totowa, N.J. Humana Press 2004 XVII, 386 S. Ill. txt rdacontent n rdamedia nc rdacarrier Current clinical oncology Includes bibliographical references and index Cancer - Immunologie Cancer - Immunothérapie Immunotherapie gtt Kanker gtt Antibody Formation Cancer Immunological aspects Cancer Immunotherapy Immunity, Cellular Immunotherapy methods Neoplasms immunology Neoplasms therapy T-Lymphocytes immunology Immuntherapie (DE-588)4026640-0 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 s Immuntherapie (DE-588)4026640-0 s DE-604 Finke, James H. Sonstige oth HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=012965959&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Cancer immunotherapy at the crossroads how tumors evade immunity and what can be done Cancer - Immunologie Cancer - Immunothérapie Immunotherapie gtt Kanker gtt Antibody Formation Cancer Immunological aspects Cancer Immunotherapy Immunity, Cellular Immunotherapy methods Neoplasms immunology Neoplasms therapy T-Lymphocytes immunology Immuntherapie (DE-588)4026640-0 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| subject_GND | (DE-588)4026640-0 (DE-588)4073781-0 |
| title | Cancer immunotherapy at the crossroads how tumors evade immunity and what can be done |
| title_auth | Cancer immunotherapy at the crossroads how tumors evade immunity and what can be done |
| title_exact_search | Cancer immunotherapy at the crossroads how tumors evade immunity and what can be done |
| title_full | Cancer immunotherapy at the crossroads how tumors evade immunity and what can be done edited by James H. Finke ... |
| title_fullStr | Cancer immunotherapy at the crossroads how tumors evade immunity and what can be done edited by James H. Finke ... |
| title_full_unstemmed | Cancer immunotherapy at the crossroads how tumors evade immunity and what can be done edited by James H. Finke ... |
| title_short | Cancer immunotherapy at the crossroads |
| title_sort | cancer immunotherapy at the crossroads how tumors evade immunity and what can be done |
| title_sub | how tumors evade immunity and what can be done |
| topic | Cancer - Immunologie Cancer - Immunothérapie Immunotherapie gtt Kanker gtt Antibody Formation Cancer Immunological aspects Cancer Immunotherapy Immunity, Cellular Immunotherapy methods Neoplasms immunology Neoplasms therapy T-Lymphocytes immunology Immuntherapie (DE-588)4026640-0 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| topic_facet | Cancer - Immunologie Cancer - Immunothérapie Immunotherapie Kanker Antibody Formation Cancer Immunological aspects Cancer Immunotherapy Immunity, Cellular Immunotherapy methods Neoplasms immunology Neoplasms therapy T-Lymphocytes immunology Immuntherapie Krebs Medizin |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=012965959&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT finkejamesh cancerimmunotherapyatthecrossroadshowtumorsevadeimmunityandwhatcanbedone |